L. Limites-de-la-prise-en-charge-de-l-'ostéoporose and .. , 54 2.1) Limites des recommandations de l, p.54

?. Comment-améliorer-la-prise-en-charge, 57 3.1) Limiter les facteurs de risque, p.57

R. Systématique-du, Evaluation, p.58

H. Autorité-de-santé, Prévention, diagnostic et traitement de l'ostéoporose, 2006.

A. Vrieze, D. Greef, M. Wijkstra, and P. , Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass, Osteoporosis International, vol.21, issue.5, pp.1197-202, 2007.
DOI : 10.1007/s00198-007-0355-7

J. Duckers, B. Evans, and W. Fraser, Low bone mineral density in men with chronic obstructive pulmonary disease, Respiratory Research, vol.5, issue.1, p.101, 2011.
DOI : 10.1016/j.artres.2011.01.001

L. Graat-verboom, M. Spruit, and B. Van-den-borne, Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component, Respiratory Medicine, vol.103, issue.8, pp.1143-51, 2009.
DOI : 10.1016/j.rmed.2009.02.014

G. Ferguson, P. Calverley, and J. Anderson, Prevalence and Progression of Osteoporosis in Patients With COPD, Chest, vol.136, issue.6, pp.1456-65, 2009.
DOI : 10.1378/chest.08-3016

L. Graat-verboom, B. Van-den-borne, and F. Smeenk, Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures, Journal of Bone and Mineral Research, vol.370, issue.(Suppl 1), pp.561-569, 2011.
DOI : 10.1002/jbmr.257

H. Ogura-tomomatsu, K. Asano, and K. Tomomatsu, Predictors of Osteoporosis and Vertebral Fractures in Patients Presenting with Moderate-to-Severe Chronic Obstructive Lung Disease, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.57, issue.4, pp.332-339, 2012.
DOI : 10.1172/JCI116387

R. Sabit, C. Bolton, and P. Edwards, Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.12, pp.1259-65, 2007.
DOI : 10.1164/rccm.200701-067OC

H. Dimai, W. Domej, and G. Leb, Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia, Journal of Bone and Mineral Research, vol.93, issue.150, pp.2132-2173, 2001.
DOI : 10.1359/jbmr.2001.16.11.2132

B. Liang and Y. Feng, The association of low bone mineral density with systemic inflammation in clinically stable COPD, Endocrine, vol.123, issue.1, pp.190-195, 2012.
DOI : 10.1007/s12020-011-9583-x

A. Coin, G. Sergi, and S. Marin, Predictors of low bone mineral density in elderly males with chronic obstructive pulmonary disease: the role of body mass index, The Aging Male, vol.31, issue.2, pp.142-149, 2010.
DOI : 10.1007/s001980070026

R. Aris, I. Neuringer, and M. Weiner, Severe Osteoporosis Before and After Lung Transplantation, Chest, vol.109, issue.5, pp.1176-83, 1996.
DOI : 10.1378/chest.109.5.1176

D. Silva, A. Coelho, and A. Dumke, Osteoporosis Prevalence and Associated Factors in Patients With COPD: A Cross-Sectional Study, Respiratory Care, vol.56, issue.7, pp.961-969, 2011.
DOI : 10.4187/respcare.01056

C. Franco, G. Paz-filho, and P. Gomes, Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D, Osteoporosis International, vol.68, issue.5, pp.1881-1888, 2009.
DOI : 10.1007/s00198-009-0890-5

N. Jørgensen, P. Schwarz, and I. Holme, The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease???a cross sectional study, Respiratory Medicine: COPD Update, vol.2, issue.3, pp.177-85, 2007.
DOI : 10.1016/j.rmedu.2006.09.008

L. Førli, O. Mellbye, and J. Halse, Cytokines, bone turnover markers and weight change in candidates for lung transplantation, Pulmonary Pharmacology & Therapeutics, vol.21, issue.1, pp.188-95, 2008.
DOI : 10.1016/j.pupt.2007.02.002

L. Li, K. Brennan, and J. Gaughan, African Americans and Men with Severe COPD Have a High Prevalence of Osteoporosis, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.123, issue.6, pp.291-298, 2008.
DOI : 10.1007/s00198-003-1449-5

S. Majumdar, C. Villa-roel, K. Lyons, and B. Rowe, Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease, Respiratory Medicine, vol.104, issue.2, pp.260-266, 2010.
DOI : 10.1016/j.rmed.2009.09.013

A. Papaioannou, W. Parkinson, and N. Ferko, Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada, Osteoporosis International, vol.14, issue.11, pp.913-920, 2003.
DOI : 10.1007/s00198-003-1449-5

R. Nuti, P. Siviero, and S. Maggi, Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study, Osteoporosis International, vol.15, issue.Suppl 46, pp.989-98, 2009.
DOI : 10.1007/s00198-008-0770-4

C. Mcevoy, K. Ensrud, and E. Bender, Association between Corticosteroid Use and Vertebral Fractures in Older Men with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.3
DOI : 10.1164/ajrccm.157.3.9703080

L. Walsh, S. Lewis, and C. Wong, The Impact of Oral Corticosteroid Use on Bone Mineral Density and Vertebral Fracture, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.5, pp.691-696, 2002.
DOI : 10.1164/rccm.2110047

K. Briot, B. Cortet, and T. Thomas, 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-317, 2012.
DOI : 10.1016/j.jbspin.2012.02.014

C. Fuhrman and M. Delmas, ??pid??miologie descriptive de la bronchopneumopathie chronique obstructive (BPCO) en France, Revue des Maladies Respiratoires, vol.27, issue.2, pp.160-168, 2010.
DOI : 10.1016/j.rmr.2009.08.003

C. Mathers and D. Loncar, Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2002.
DOI : 10.1371/journal.pmed.0030442.st007

K. Briot, B. Cortet, and F. Trémollières, Male osteoporosis: Diagnosis and fracture risk evaluation, Joint Bone Spine, vol.76, issue.2, pp.129-162, 2009.
DOI : 10.1016/j.jbspin.2008.07.014

URL : https://hal.archives-ouvertes.fr/inserm-00395613

S. Schuit, M. Van-der-klift, and A. Weel, Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study, Bone, vol.34, issue.1, pp.195-202, 2004.
DOI : 10.1016/j.bone.2003.10.001

A. Kjensli, P. Mowinckel, M. Ryg, and J. Falch, Low bone mineral density is related to severity of chronic obstructive pulmonary disease, Bone, vol.40, issue.2, pp.493-500, 2007.
DOI : 10.1016/j.bone.2006.09.005

A. Papaioannou, C. Kennedy, and A. Cranney, Risk factors for low BMD in healthy men age 50??years or older: a systematic review, Osteoporosis International, vol.26, issue.4, pp.507-525, 2009.
DOI : 10.1007/s00198-008-0720-1

M. Aubier, R. Marthan, and P. Berger, BPCO et inflammation: mise au point d???un groupe d???experts. Les m??canismes de l???inflammation et du remodelage, Revue des Maladies Respiratoires, vol.27, issue.10, pp.1254-66, 2010.
DOI : 10.1016/j.rmr.2010.10.004

P. Bai, Y. Sun, and J. Jin, Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis, Respiratory Research, vol.35, issue.1, p.157, 2011.
DOI : 10.1183/09031936.00088209

R. Hardy and M. Cooper, Bone loss in inflammatory disorders, Journal of Endocrinology, vol.201, issue.3, pp.309-329, 2009.
DOI : 10.1677/JOE-08-0568

A. Lehouck, S. Boonen, M. Decramer, and W. Janssens, COPD, Bone Metabolism, and Osteoporosis, Chest, vol.139, issue.3, pp.648-57, 2011.
DOI : 10.1378/chest.10-1427

URL : http://journal.publications.chestnet.org/data/Journals/CHEST/23324/110047.pdf

V. Locascio, E. Bonucci, and B. Imbimbo, Bone loss in response to long-term glucocorticoid therapy, Bone and Mineral, vol.8, issue.1, pp.39-51, 1990.
DOI : 10.1016/0169-6009(91)90139-Q

I. Reid, M. Evans, and D. Wattie, Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients, Osteoporosis International, vol.150, issue.2, pp.103-108, 1992.
DOI : 10.1007/BF01623844

R. Mckenzie, J. Reynolds, O. Fallon, and A. , Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial, J Rheumatol, vol.27, issue.9, pp.2222-2228, 2000.

L. Walsh, C. Wong, and J. Oborne, Adverse effects of oral corticosteroids in relation to dose in patients with lung disease, Thorax, vol.56, issue.4, pp.279-84, 2001.
DOI : 10.1136/thorax.56.4.279

C. Wong, L. Walsh, and C. Smith, Inhaled corticosteroid use and bone-mineral density in patients with asthma, The Lancet, vol.355, issue.9213, pp.1399-403, 2000.
DOI : 10.1016/S0140-6736(00)02138-3

S. Gonnelli, C. Caffarelli, and S. Maggi, Effect of Inhaled Glucocorticoids and ??2 Agonists on Vertebral Fracture Risk in COPD Patients: The EOLO Study, Calcified Tissue International, vol.12, issue.Suppl 11, pp.137-180, 2010.
DOI : 10.1007/s00223-010-9392-x

R. Pauwels, C. Löfdahl, and L. Laitinen, Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking, New England Journal of Medicine, vol.340, issue.25, pp.1948-53, 1999.
DOI : 10.1056/NEJM199906243402503

P. Burge, P. Calverley, and P. Jones, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, issue.7245, pp.1297-303, 2000.
DOI : 10.1136/bmj.320.7245.1297

P. Scanlon, J. Connett, and R. Wise, Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.12, pp.1302-1311, 2004.
DOI : 10.1164/rccm.200310-1349OC

E. Romme, E. Rutten, and F. Smeenk, Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease, Annals of Medicine, vol.22, issue.1, pp.91-97, 2013.
DOI : 10.1016/j.rmed.2009.12.007

E. Murry, Actualités sur la vitamine D et nouvelles perspectives thérapeutiques. Thèse d'exercice en pharmacie, 2011.

K. Lyles, D. Gold, and K. Shipp, Association of osteoporotic vertebral compression fractures with impaired functional status, The American Journal of Medicine, vol.94, issue.6, pp.595-601, 1993.
DOI : 10.1016/0002-9343(93)90210-G

M. Nevitt, B. Ettinger, and D. Black, The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study, Annals of Internal Medicine, vol.128, issue.10, pp.793-800, 1998.
DOI : 10.7326/0003-4819-128-10-199805150-00001

J. Leech, C. Dulberg, S. Kellie, L. Pattee, and J. Gay, Relationship of Lung Function to Severity of Osteoporosis in Women, American Review of Respiratory Disease, vol.141, issue.1, pp.68-71, 1990.
DOI : 10.1164/ajrccm/141.1.68

D. Kado, W. Browner, and L. Palermo, Vertebral Fractures and Mortality in Older Women, Archives of Internal Medicine, vol.159, issue.11, pp.1215-1235, 1999.
DOI : 10.1001/archinte.159.11.1215

H. Genant, C. Wu, C. Van-kuijk, and M. Nevitt, Vertebral fracture assessment using a semiquantitative technique, Journal of Bone and Mineral Research, vol.13, issue.S1, pp.1137-1185, 1993.
DOI : 10.1002/jbmr.5650080915

M. Schürch, R. Rizzoli, and B. Mermillod, A prospective study on socioeconomic aspects of fracture of the proximal femur, Journal of Bone and Mineral Research, vol.307, issue.12, pp.1935-1977, 1996.
DOI : 10.1002/jbmr.5650111215

S. Bouee, A. Lafuma, and F. Fagnani, Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries, Rheumatology International, vol.115, issue.8, pp.1063-72, 2006.
DOI : 10.1007/s00296-006-0180-x

E. Dubljanin-raspopovi?, L. Markovi?-deni?, and J. Marinkovi?, Does Early Functional Outcome Predict 1-year Mortality in Elderly Patients With Hip Fracture?, Clinical Orthopaedics and Related Research??, vol.390, issue.8, 2013.
DOI : 10.1007/s11999-013-2955-1

C. De-luise, M. Brimacombe, L. Pedersen, and H. Sørensen, Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study, European Journal of Epidemiology, vol.51, issue.SS06, pp.115-137, 2008.
DOI : 10.1007/s10654-007-9211-5

P. Fardellone, J. Sebert, and M. Bouraya, Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, vol.58, issue.2, pp.99-103, 1991.

A. Martin and A. , Apports nutritionnels conseillés pour la population française. 3ème édition. Tec&Doc, 2001.

D. La-vitamine, adulte : recommandations du GRIO, La Presse Médicale, vol.40, issue.78, pp.673-82, 2011.

A. Avenell, W. Gillespie, L. Gillespie, O. Connell, and D. , Vitamin D and vitamin D analogues for preventing fractures associated with involutional and postmenopausal osteoporosis, Cochrane Database Syst Rev, issue.2, p.227, 2009.

J. Bilezikian, Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis, The American Journal of Medicine, vol.122, issue.2, pp.14-21, 2009.
DOI : 10.1016/j.amjmed.2008.12.003

M. Doga, S. Bonadonna, and A. Burattin, Bisphosphonates in the Treatment of Glucocorticoid-Induced Osteoporosis, Front Horm Res, vol.30, pp.150-64, 2002.
DOI : 10.1159/000061082

B. Smith, L. Laslett, and K. Pile, Randomized controlled trial of alendronate in airways disease and low bone mineral density, Chronic Respiratory Disease, vol.1, issue.3, pp.131-138, 2004.
DOI : 10.1191/1479972304cd025oa

E. Lau, J. Woo, Y. Chan, and M. Li, Alendronate for the prevention of bone loss in patients on inhaled steroid therapy, Bone, vol.29, issue.6, pp.506-516, 2001.
DOI : 10.1016/S8756-3282(01)00611-1

A. Sawka, A. Papaioannou, J. Adachi, A. Gafni, D. Hanley et al., Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women, BMC Musculoskeletal Disorders, vol.23, issue.2, p.39, 2005.
DOI : 10.1210/er.2001-8002

J. Ringe, H. Faber, P. Farahmand, and A. Dorst, Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study, Rheumatology International, vol.11, issue.1, pp.427-458, 2006.
DOI : 10.1007/s00296-005-0004-4

N. Pauchard, Evaluation du dépistage de l'ostéoporose selon les recommandations de l'HAS de 2006: étude auprès des femmes de 50 ans et plus en médecine de ville à Paris, Thèse d'exercice de médecine, 2012.

A. Payard, Evaluation de la pratique du dépistage de l'ostéoporose féminine en médecine générale: enquête auprès de 150 médecins généralistes en Midi- Pyrénées. Thèse d'exercice de médecine, 2009.

M. Audran and B. Cortet, Identification par l???analyse des facteurs cliniques de risque et la densitom??trie osseuse des hommes ?? risque d???ost??oporose, La Presse M??dicale, vol.40, issue.11, pp.489-98, 2011.
DOI : 10.1016/j.lpm.2011.08.002

S. Gehlbach, C. Bigelow, M. Heimisdottir, S. May, M. Walker et al., Recognition of Vertebral Fracture in a Clinical Setting, Osteoporosis International, vol.11, issue.7, pp.577-82, 2000.
DOI : 10.1007/s001980070078

P. Sutter, P. Fardellone, and P. Dargent, XXIème journée scientifique du GRIO: Calcul des apports calciques quotidiens " en ligne " sur le site du GRIO : premiers résultats

R. Nuti, Calcium supplementation and risk of cardiovascular disease, Clin Cases Miner Bone Metab, vol.20129, issue.3, pp.133-137

. Diphosphonates, les résultats de quelques essais incitent à la prudence, Prescrire, issue.30, pp.908-918, 2010.

M. Buisson, Décision médicale partagée: observation des pratiques de dépistage du cancer de la prostate en médecine générale. Thèse d'exercice de médecine, 2010.